Ozempic and Wegovy: stopping treatment increases the risk of stroke by 22%

A large American study reveals that interrupting GLP-1 treatments such as Ozempic increases the risk of…

Novo Nordisk revolutionizes the fight against obesity with oral treatment

The Danish pharmaceutical giant takes a new major step in the field of treatments against obesity.…